Smooth muscle cell-specific knockout of androgen receptor: a new model for prostatic disease.
暂无分享,去创建一个
Lee B. Smith | R. Sharpe | A. Mcneilly | P. Saunders | M. Welsh | D. Brownstein | L. Moffat | A. McNeilly
[1] Hong-Chiang Chang,et al. Altered prostate epithelial development and IGF‐1 signal in mice lacking the androgen receptor in stromal smooth muscle cells , 2011, The Prostate.
[2] Lee B. Smith,et al. Deletion of Androgen Receptor in the Smooth Muscle of the Seminal Vesicles Impairs Secretory Function and Alters Its Responsiveness to Exogenous Testosterone and Estradiol , 2010, Endocrinology.
[3] Lee B. Smith,et al. Androgen action via testicular peritubular myoid cells is essential for male fertility , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[4] M. Shen,et al. A luminal epithelial stem cell that is a cell of origin for prostate cancer , 2009, Nature.
[5] P. Stattin,et al. Low stroma androgen receptor level in normal and tumor prostate tissue is related to poor outcome in prostate cancer patients , 2009, The Prostate.
[6] Madhuchhanda Bhattacharjee,et al. Conserved gene expression programs integrate mammalian prostate development and tumorigenesis. , 2009, Cancer research.
[7] Robert P. Hooley,et al. Intra-testicular injection of adenoviral constructs results in Sertoli cell-specific gene expression and disruption of the seminiferous epithelium. , 2009, Reproduction.
[8] S. Yeh,et al. Targeting the stromal androgen receptor in primary prostate tumors at earlier stages , 2008, Proceedings of the National Academy of Sciences.
[9] J. Macoska,et al. The inflammatory microenvironment of the aging prostate facilitates cellular proliferation and hypertrophy. , 2008, Cytokine.
[10] N. Maitland,et al. Androgen receptor signalling in prostate: Effects of stromal factors on normal and cancer stem cells , 2008, Molecular and Cellular Endocrinology.
[11] Lee B. Smith,et al. Identification in rats of a programming window for reproductive tract masculinization, disruption of which leads to hypospadias and cryptorchidism. , 2008, The Journal of clinical investigation.
[12] K. Gravdal,et al. A Switch from E-Cadherin to N-Cadherin Expression Indicates Epithelial to Mesenchymal Transition and Is of Strong and Independent Importance for the Progress of Prostate Cancer , 2007, Clinical Cancer Research.
[13] S. Yeh,et al. Increased prostate cell proliferation and loss of cell differentiation in mice lacking prostate epithelial androgen receptor , 2007, Proceedings of the National Academy of Sciences.
[14] David Handelsman,et al. Disruption of prostate epithelial androgen receptor impedes prostate lobe-specific growth and function. , 2007, Endocrinology.
[15] O. Witte,et al. Isolation and functional characterization of murine prostate stem cells , 2007, Proceedings of the National Academy of Sciences.
[16] Yuzhuo Wang,et al. Steroid hormones stimulate human prostate cancer progression and metastasis , 2006, International journal of cancer.
[17] M. Gleave,et al. NKX3.1 stabilizes p53, inhibits AKT activation, and blocks prostate cancer initiation caused by PTEN loss. , 2006, Cancer cell.
[18] A. Thomson,et al. Hormonal, cellular, and molecular regulation of normal and neoplastic prostatic development , 2004, The Journal of Steroid Biochemistry and Molecular Biology.
[19] A. Mills,et al. Role of p63 and basal cells in the prostate , 2004, Development.
[20] C. Robson,et al. CD133, a novel marker for human prostatic epithelial stem cells , 2004, Journal of Cell Science.
[21] M. Rubin,et al. Prostate Pathology of Genetically Engineered Mice: Definitions and Classification. The Consensus Report from the Bar Harbor Meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee , 2004, Cancer Research.
[22] M. Shen,et al. Roles of the Nkx3.1 homeobox gene in prostate organogenesis and carcinogenesis , 2003, Developmental dynamics : an official publication of the American Association of Anatomists.
[23] P. Scardino,et al. Reactive stroma as a predictor of biochemical-free recurrence in prostate cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[24] P. Nelson,et al. Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. , 2003, Cancer cell.
[25] S. Hayward,et al. Role of stroma in carcinogenesis of the prostate. , 2002, Differentiation; research in biological diversity.
[26] M. Kotlikoff,et al. Smooth muscle expression of Cre recombinase and eGFP in transgenic mice. , 2002, Physiological genomics.
[27] K. Pienta,et al. E-cadherin expression in prostate cancer: a broad survey using high-density tissue microarray technology. , 2001, Human pathology.
[28] J. Gustafsson,et al. Evidence that epithelial and mesenchymal estrogen receptor-alpha mediates effects of estrogen on prostatic epithelium. , 2001, Developmental biology.
[29] R Montironi,et al. p63 is a prostate basal cell marker and is required for prostate development. , 2000, The American journal of pathology.
[30] K. Korach,et al. Tissue Distribution and Quantitative Analysis of Estrogen Receptor-α (ERα) and Estrogen Receptor-β (ERβ) Messenger Ribonucleic Acid in the Wild-Type and ERα-Knockout Mouse. , 1997, Endocrinology.
[31] R. Dahiya,et al. Smooth muscle-epithelial interactions in normal and neoplastic prostatic development. , 1996, Acta anatomica.
[32] P. Saunders,et al. Immunolocalisation of androgen receptor to interstitial cells in fetal rat testes and to mesenchymal and epithelial cells of associated ducts. , 1995, The Journal of endocrinology.
[33] F. S. French,et al. Androgen receptor defects: historical, clinical, and molecular perspectives. , 1995, Endocrine reviews.
[34] G. Cunha,et al. Assessment of prostatic protein secretion in tissue recombinants made of urogenital sinus mesenchyme and urothelium from normal or androgen-insensitive mice. , 1993, Endocrinology.
[35] A. Donjacour,et al. Normal and abnormal development of the male urogenital tract. Role of androgens, mesenchymal-epithelial interactions, and growth factors. , 1992, Journal of andrology.
[36] A. Currie. The Beatson Institute for Cancer Research and Dr John Paul. , 1988 .
[37] Mcneal Je. Normal anatomy of the prostate and changes in benign prostatic hypertrophy and carcinoma , 1988 .
[38] J. Morley,et al. Biological actions of androgens. , 1987, Endocrine reviews.
[39] W. Birchmeier,et al. Cell-cell interaction and polarity of epithelial cells: Specific perturbation using a monoclonal antibody , 1983, Cell.
[40] P. Riddle,et al. A comparative study of the ultrastructure and lack of growth capacity of adult human prostate epithelium mechanically separated from its stroma , 1970, The Journal of pathology.
[41] M. Bosland,et al. The role of stromal cells in prostate cancer development and progression. , 1999, In vivo.
[42] J. McNeal. Normal anatomy of the prostate and changes in benign prostatic hypertrophy and carcinoma. , 1988, Seminars in ultrasound, CT, and MR.
[43] J. D. Neill,et al. The Physiology of reproduction , 1988 .
[44] G. Cunha,et al. Stromal-epithelial interactions in normal and abnormal prostatic development. , 1987, Progress in clinical and biological research.
[45] L. Chung,et al. Stromal‐epithelial interactions: II. Regulation of prostatic growth by embryonic urogenital sinus mesenchyme , 1983, The Prostate.
[46] K. Gräf,et al. Hormonal control of sexual development. , 1974, Advances in the biosciences.
[47] David Handelsman,et al. Printed in U.S.A. Copyright © 2002 by The Endocrine Society doi: 10.1210/en.2002-220493 Direct Response of the Murine Prostate Gland and Seminal Vesicles to Estradiol , 2022 .